Načítá se...
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
BACKGROUND: In drug development, it is important to have an understanding of the full spectrum of co-morbidities to be expected in the group of patients with the disease of interest. It is usually a challenge to identify the less common events associated with the target disease, even if these events...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2987972/ https://ncbi.nlm.nih.gov/pubmed/20973999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-11-247 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|